Business Description
Vivo Bio Tech Ltd
NAICS : 325412
ISIN : INE380K01017
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 1.66 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.42 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.5 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | -39.1 | |||||
3-Year Book Growth Rate | 10.7 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.47 | |||||
9-Day RSI | 47.17 | |||||
14-Day RSI | 49.38 | |||||
6-1 Month Momentum % | 33.13 | |||||
12-1 Month Momentum % | 87.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 761.37 | |||||
Days Sales Outstanding | 90.13 | |||||
Days Payable | 84.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | 7.19 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 91.53 | |||||
Operating Margin % | 28.33 | |||||
Net Margin % | 7.95 | |||||
FCF Margin % | 6.95 | |||||
ROE % | 7.51 | |||||
ROA % | 3.16 | |||||
ROIC % | 8.05 | |||||
ROC (Joel Greenblatt) % | 14.04 | |||||
ROCE % | 14.07 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.21 | |||||
PE Ratio without NRI | 17.21 | |||||
Shiller PE Ratio | 18.57 | |||||
PEG Ratio | 2.49 | |||||
PS Ratio | 1.37 | |||||
PB Ratio | 1.27 | |||||
Price-to-Tangible-Book | 1.55 | |||||
Price-to-Free-Cash-Flow | 19.69 | |||||
Price-to-Operating-Cash-Flow | 9 | |||||
EV-to-EBIT | 9.08 | |||||
EV-to-EBITDA | 5.46 | |||||
EV-to-Revenue | 2.58 | |||||
EV-to-FCF | 37.11 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.15 | |||||
Price-to-Graham-Number | 1.31 | |||||
Earnings Yield (Greenblatt) % | 11.01 | |||||
FCF Yield % | 5.07 | |||||
Forward Rate of Return (Yacktman) % | -3.72 |